CartiHeal (Israel) Performs the First 16 Cases in the Agili-C™ Implant IDE Multinational Pivotal Study

CartiHeal, developer of Agili-C, proprietary implants for the treatment of joint surface lesions, announced today the initiation of Its IDE clinical study. 16 patients were enrolled and operated on during the first week of the study in 3 leading European…